Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Salvia pratensis
European meadow sage with antibiotic properties; used in folk medicine for throat and skin conditions.
Salvia pratensis (European meadow sage) is a herb traditionally used for sore throat, skin infections, and digestive disorders, with modern applications as an antimicrobial, anti-inflammatory, astringent, and antioxidant. Its key active compounds include rosmarinic acid, luteolin, apigenin, ursolic acid, and oleanolic acid, which contribute to its therapeutic effects. Evidence level C supports its use, primarily from in vitro and limited clinical studies.
The antimicrobial activity is attributed to rosmarinic acid and ursolic acid disrupting bacterial cell membranes and inhibiting biofilm formation. Anti-inflammatory effects involve inhibition of COX-2 and 5-LOX pathways, as well as modulation of NF-κB signaling. Astringent properties are due to tannins and flavonoids binding to mucosal proteins, while antioxidant action is mediated by rosmarinic acid and luteolin scavenging free radicals and upregulating endogenous antioxidant enzymes.
European meadow sage with antibiotic properties; used in folk medicine for throat and skin conditions.
Salvia pratensis (European meadow sage) is a herb traditionally used for sore throat, skin infections, and digestive disorders, with modern applications as an antimicrobial, anti-inflammatory, astringent, and antioxidant. Its key active compounds include rosmarinic acid, luteolin, apigenin, ursolic acid, and oleanolic acid, which contribute to its therapeutic effects. Evidence level C supports its use, primarily from in vitro and limited clinical studies.
The antimicrobial activity is attributed to rosmarinic acid and ursolic acid disrupting bacterial cell membranes and inhibiting biofilm formation. Anti-inflammatory effects involve inhibition of COX-2 and 5-LOX pathways, as well as modulation of NF-κB signaling. Astringent properties are due to tannins and flavonoids binding to mucosal proteins, while antioxidant action is mediated by rosmarinic acid and luteolin scavenging free radicals and upregulating endogenous antioxidant enzymes.